DR. REDDY’S LABORATORIES LIMITED (RDY)

12.18 +0.16% (+0.02)

Over 1Y: -13.4%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

12 14
Aug Oct Dec Feb Apr Jun Aug

Financials Annual

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
FY21 — Revenue: 2.6B FY21 — Operating Cash Flow: 488M FY21 — Free Cash Flow: 355M FY21 — Net Income: 236M FY22 — Revenue: 2.8B FY22 — Operating Cash Flow: 370M FY22 — Free Cash Flow: 177M FY22 — Net Income: 311M FY23 — Revenue: 3B FY23 — Operating Cash Flow: 716M FY23 — Free Cash Flow: 578M FY23 — Net Income: 548M FY24 — Revenue: 3.4B FY24 — Operating Cash Flow: 545M FY24 — Free Cash Flow: 348M FY24 — Net Income: 668M FY25 — Revenue: 3.8B FY25 — Operating Cash Flow: 545M FY25 — Free Cash Flow: 223M FY25 — Net Income: 671M 0 800M 1.6B 2.4B 3.2B 4B
FY21 FY22 FY23 FY24 FY25
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2025-03-31, reported in USD. The newest fact in the filings is dated 2025-03-31, 517 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

5.1
SBC / sales 0.13%
Oper. margin 22.1%
ROIC 15.6%
OE margin 5.7%
ROA 11.6%
ROCE 19.8%
Gross margin 58.5%
ROE 17.2%
Accruals 2.2%
FCF margin 5.9%
OCF margin 14.3%
OCF / EBIT 0.65×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

7.3
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.7
ND/EBITDA —
Debt / Eq 0.14×
Net debt / Eq 0.094×
Payout 11.6%
Debt payback 1.6 yr
Quick ratio 1.4×
Cash / Debt 0.32×
F-score 2.0 pts
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.6
Sales/sh Y/Y +13.7%
Sales CAGR 4Y +10.1%
Shares change +0.077%
EBIT CAGR +26.2%
EPS Y/Y +0.37%
Div. growth -2.5%
EBIT Y/Y +3.6%
EPS CAGR 4Y —
EPS next Y —
Sales Q/Q —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.